Kevin Lee Bicycle Therapeutics PLC (BCYC) insider trading activity

Kevin Lee is CHIEF EXECUTIVE OFFICER of BICYCLE THERAPEUTICS plc. Currently has a direct ownership of 380,864 shares of BCYC, which is worth approximately $7.75 Million. The most recent transaction as insider was on Oct 03, 2024, when has been sold 3,212 shares (Ordinary Shares) at a price of $22.26 per share, resulting in proceeds of $71,499. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 381K

0.84% 3M change

18.23% 12M change

Total Value Held $7.75 Million

Kevin Lee Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 03 2024	SELL Open market or private sale	$71,499 $22.26 p/Share	3,212 Reduced 0.84%	380,864 Ordinary Shares
Jul 03 2024	SELL Open market or private sale	$62,730 $19.64 p/Share	3,194 Reduced 0.82%	384,076 Ordinary Shares
Apr 03 2024	SELL Open market or private sale	$75,191 $23.81 p/Share	3,158 Reduced 0.81%	387,270 Ordinary Shares
Jan 03 2024	SELL Open market or private sale	$152,302 $17.5 p/Share	8,703 Reduced 2.18%	390,428 Ordinary Shares
Jan 02 2024	BUY Grant, award, or other acquisition	-	77,000 Added 16.17%	399,131 Ordinary Shares
Oct 03 2023	SELL Open market or private sale	$29,400 $20.0 p/Share	1,470 Reduced 0.45%	322,131 Ordinary Shares
Jul 03 2023	SELL Open market or private sale	$37,599 $25.1 p/Share	1,498 Reduced 0.46%	323,601 Ordinary Shares
Apr 03 2023	SELL Open market or private sale	$31,369 $21.11 p/Share	1,486 Reduced 0.46%	325,099 Ordinary Shares
Jan 03 2023	SELL Open market or private sale	$174,360 $29.06 p/Share	6,000 Reduced 1.8%	326,585 Ordinary Shares
Jan 03 2023	BUY Grant, award, or other acquisition	-	57,500 Added 14.74%	332,585 Ordinary Shares
Jan 03 2022	BUY Grant, award, or other acquisition	-	50,000 Added 15.38%	275,085 Ordinary Shares
Oct 18 2021	SELL Open market or private sale	$2,940 $60.0 p/Share	49 Reduced 0.02%	225,085 Ordinary Shares
Oct 15 2021	SELL Open market or private sale	$19,216 $60.05 p/Share	320 Reduced 0.14%	225,134 Ordinary Shares
Oct 14 2021	SELL Open market or private sale	$277,860 $60.0 p/Share	4,631 Reduced 2.01%	225,454 Ordinary Shares
Oct 11 2021	SELL Open market or private sale	$271,100 $54.22 p/Share	5,000 Reduced 2.13%	230,085 Ordinary Shares
Sep 02 2021	SELL Open market or private sale	$200,000 $40.0 p/Share	5,000 Reduced 2.08%	235,085 Ordinary Shares
Sep 01 2021	SELL Open market or private sale	$1,011,083 $37.33 p/Share	27,085 Reduced 10.14%	240,085 Ordinary Shares
Sep 01 2021	BUY Exercise of conversion of derivative security	$320,460 $14.0 p/Share	22,890 Added 7.89%	267,170 Ordinary Shares
Aug 31 2021	SELL Open market or private sale	$411,508 $36.66 p/Share	11,225 Reduced 4.39%	244,280 Ordinary Shares
Aug 31 2021	BUY Exercise of conversion of derivative security	$145,880 $14.0 p/Share	10,420 Added 3.92%	255,505 Ordinary Shares
Aug 27 2021	SELL Open market or private sale	$65,124 $36.02 p/Share	1,808 Reduced 0.73%	245,085 Ordinary Shares
Aug 27 2021	BUY Exercise of conversion of derivative security	$25,312 $14.0 p/Share	1,808 Added 0.73%	246,893 Ordinary Shares
Jul 26 2021	SELL Open market or private sale	$3,600 $36.0 p/Share	100 Reduced 0.04%	245,085 Ordinary Shares
Jul 26 2021	BUY Exercise of conversion of derivative security	$1,400 $14.0 p/Share	100 Added 0.04%	245,185 Ordinary Shares
Jul 23 2021	SELL Open market or private sale	$172,248 $36.02 p/Share	4,782 Reduced 1.91%	245,085 Ordinary Shares

Kevin Lee

CHIEF EXECUTIVE OFFICER

Cambridge, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCYC shares.

Notify only if

Value

Insider Trading

Get notified when an Bicycle Therapeutics PLC insider buys or sells BCYC shares.

Notify only if

Operation

Value

Type

News

Receive news related to BICYCLE THERAPEUTICS plc

Track Activities on BCYC

Account